Eye supplements market was valued at US$ 1.5 Bn in 2019 and poised to grow at CAGR 6.3%. over 2020 to 2026. The Report gives comprehensive outlook on eye nutrition supplements across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report on gives historical, current, and future market sizes (US$ Mn) of product type, dosage form, distribution channel, and geographic regions. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes recent product launches, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analysed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the eye nutrition supplements market report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply of eye nutrition supplements. Eye supplements market is highly fragmented as many players operating in eye nutrition supplements. Companies are adopting different growth strategies to enhance their sales revenue. Few companies adopted acquisitions, product launches, novel product claims, new distribution channels, collaborating with retail stores, educating ophthalmologists, and social media marketing are some of the key strategies. In 2015, Alliance Pharma plc, acquired MacuVision Europe Limited (MacuVision) for £ 5.5 Mn to add eye care portfolio. As a part of differentiating strategy, Bausch + Lomb (Valeant) product PreserVision Eye Vitamin AREDS Formula Tablets claimed on their product label “Doctor #1 Recommended” to gain confidence from consumers.